carbapenems has been researched along with gemifloxacin in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (gemifloxacin) | Trials (gemifloxacin) | Recent Studies (post-2010) (gemifloxacin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 320 | 46 | 80 |
| Protein | Taxonomy | carbapenems (IC50) | gemifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.6 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.3 | |
| DNA gyrase subunit A | Staphylococcus aureus | 5.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, EJ | 1 |
1 other study(ies) available for carbapenems and gemifloxacin
| Article | Year |
|---|---|
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |